About us

Angelini Pharma is the pharmaceutical division of Angelini Industries. The Group started almost 100 years ago as a small pharmaceutical laboratory, and over the years has grown into a leading international group in healthcare, present in Pharmaceuticals and Mass-Market.

Angelini Pharma is a leader in healthcare, with particular strength and expertise in the field of Brain Health, including Mental Health and Epilepsy. The company is also a leading player in the Consumer Health segment, with highly successful OTC brands worldwide.

Angelini Pharma's products are marketed in approximately 70 countries. The company operates directly in 20 countries, employing nearly 3,000 people, and distributes its products in over 70 countries through strategic alliances with leading international pharmaceutical groups.

As part of its internationalisation strategy, Angelini Pharma has also concentrated on development in countries with high growth potential.

Angelini Pharma reported a turnover of €1,2 billion in 2024, about half accounted for by exports.

Angelini Pharma's “world class” production plants use cutting-edge technologies and have full certification for quality standards and respect for the environment.